IRAK4 and COVID-19: Viruses can enter platelets, activate endosomal TLRs (TLR7/TLR9) and downstream MYD88-IRAK4-IRAK1-IKKβ (and presumably IRF5), possibly contributing to COVID-19 thrombocytopenia and clotting irregularities (103, 104).